Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma. - Wikidata - wikimedia - TriplyDB

Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma.

Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma.

http://www.wikidata.org/entity/Q34203742

about

Genetic susceptibility to Barrett's oesophagus: Lessons from early studies Recent developments in esophageal adenocarcinoma Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease Risk Factors for Barrett's Oesophagus Barrett's oesophagus: frequency and prediction of dysplasia and cancer Genomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective.High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.Endoscopic assessment and management of early esophageal adenocarcinoma CTHRC1 is associated with peritoneal carcinomatosis in colorectal cancer: a new predictor for prognosis.Barrett's oesophagus: epidemiology, cancer risk and implications for management.Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions.Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus.Barrett esophagus: history, definition and etiopathogeny MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma.Construction and analysis of three networks of genes and microRNAs in adenocarcinoma TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling Macrophage scavenger receptor a promotes tumor progression in murine models of ovarian and pancreatic cancer.Linkage and related analyses of Barrett's esophagus and its associated adenocarcinomas.Single nucleotide polymorphisms of caudal type homeobox 1 and 2 are associated with Barrett's esophagus.Site-specific methylated reporter constructs for functional analysis of DNA methylation.Hereditary Factors in Esophageal Adenocarcinoma.Esophageal Cancer: New Insights into a Heterogenous Disease.The Genetics of Barrett's Esophagus: A Familial and Population-Based Perspective.Common Variants Confer Susceptibility to Barrett's Esophagus: Insights from the First Genome-Wide Association Studies.The Evolving Genomic Landscape of Barrett's Esophagus and Esophageal Adenocarcinoma.Association Between Germline Mutation in VSIG10L and Familial Barrett Neoplasia.Collagen triple helix repeat containing-1 (CTHRC1) expression in invasive ductal carcinoma of the breast: the impact on prognosis and correlation to clinicopathologic features.Organ specificity of beta-carotene induced lung gene-expression changes in Bcmo1-/- mice.Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence.The new neuromuscular disease related with defects in the ASC-1 complex: report of a second case confirms ASCC1 involvement.Germline variant in MSX1 identified in a Dutch family with clustering of Barrett's esophagus and esophageal adenocarcinoma.Recent Advances in Screening for Barrett's Esophagus.Association of sporadic and familial Barrett's esophagus with breast cancer.Genetics of Barrett's: the bigger, the better.Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility

P2860

Q26740556-3B183730-A702-4891-93A5-01BC1B4458D7 Q26849652-AA723E23-9B87-4F96-A97C-7FE23FBAE2C6 Q26991754-556BA28E-4F7E-4E8E-98FA-1A9A4F0BFC45 Q28076807-DBF35EC9-CA18-45C3-9D0A-079A3CF9B1DD Q28080794-AFFDB809-EC9A-4BCB-A54D-A0418D040957 Q33600507-DF55E482-7FA2-412C-AA45-4606916E9558 Q33827629-989B056B-1ED1-4A0E-A427-1D1A4ADFD7E7 Q34049117-4E70C83B-2297-4170-89D8-BD737147BAA3 Q34325001-55F0AECF-7A71-41B4-9173-E9893EFC00AD Q34375216-8A5B654F-5A99-4129-AB90-C05C90DA9D19 Q34624586-18A5E032-A36E-4985-AD6E-7B6B0DD1B710 Q35042479-265A4394-4C8C-4C4E-90D9-2ED1EE4566D8 Q35340490-5F5917FE-9F0E-4008-B75E-EF361983FC3F Q35651285-2F973EEC-E5E0-41D5-AADC-5CAB0AB71715 Q35666515-C09EF2DB-01D8-44F3-BF99-83BEBBAED8C5 Q36109030-5F9BC563-0B1D-4825-ABCD-6051E7186F91 Q36334576-652F0BD5-88AD-4473-8660-13ADAF657A2C Q36544919-372869CE-1C82-4EF6-9251-41089139B63D Q36717573-50E5C573-B2EB-444D-A400-07A7EA0FA081 Q37101225-F1C66F13-3DB6-412D-BB15-B0F1EEA7E595 Q37625982-94E277F1-7110-40EF-846C-8CC02CD76E45 Q38312821-C2B0F422-9C03-4466-AC58-757D3ED9FA5E Q38671337-AA907BFD-99DE-4734-A685-F3A95109F8B8 Q38734003-1D968550-B4BF-4844-9E28-E31232B7CDD5 Q38771931-C6DB9220-3C59-49A4-86AA-5C8EFFE1EFE4 Q38940534-4F343049-B61E-4A35-94DC-9FC077648AC5 Q39440077-81C08764-A08A-40C1-8CAC-889DB248433C Q41652261-F79867B7-A43F-48C2-B5D1-4B1AB08ADCCC Q43971709-6A58BEF8-2EEC-4777-8146-C3448898AD68 Q46454893-396E262D-51BB-47CC-BDB6-A6AA4B766D44 Q47786705-1345C3EF-56F8-43E8-900E-A52A480F913E Q47853195-E83127C9-139C-44E8-B314-9B1184111AC5 Q50037163-C7328F95-EB7D-4F62-8DC3-D2AC57D32247 Q50057605-0230A0E4-58A3-4CFD-AD25-42C34DE72C71 Q52661117-DB3C6CAD-210C-458D-A39E-126D9DC7AA3D Q53818029-6C7A4AEE-5BEB-4392-9D6A-12A92BF55627 Q58930584-0F39F642-2829-4186-A4AB-89F9F8DE9C99

P2860

Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma.

http://www.wikidata.org/entity/Q34203742

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Germline mutations in MSR1, AS ...... and esophageal adenocarcinoma.

@ast

Germline mutations in MSR1, AS ...... and esophageal adenocarcinoma.

@en

Germline mutations in MSR1, AS ...... and esophageal adenocarcinoma.

@nl

type

label

Germline mutations in MSR1, AS ...... and esophageal adenocarcinoma.

@ast

Germline mutations in MSR1, AS ...... and esophageal adenocarcinoma.

@en

Germline mutations in MSR1, AS ...... and esophageal adenocarcinoma.

@nl

prefLabel

Germline mutations in MSR1, AS ...... and esophageal adenocarcinoma.

@ast

Germline mutations in MSR1, AS ...... and esophageal adenocarcinoma.

@en

Germline mutations in MSR1, AS ...... and esophageal adenocarcinoma.

@nl

P1433

Q34203742-905A5C69-C1EA-40F9-9367-77AEBD502C8F

P1476

Q34203742-24AC1DB1-E595-4680-A3A7-5ED6639B5ECD

P2093

Q34203742-0D593EEE-8709-4AFB-A2C7-2DCCE981949F

Q34203742-161D570B-6C45-4AFF-84E5-6F3800113377

Q34203742-276CF8B4-7288-4B20-9624-48EF4335C60B

Q34203742-284D48F7-A168-4732-B01B-DF51831B6310

Q34203742-28C4B703-217A-475E-8DA9-1BC9B499A0FF

Q34203742-3EE1C803-F186-481B-A6EE-212ACA12F152

Q34203742-5800A347-A7BD-41F0-AEBC-102F00EC8343

Q34203742-6A31F0F4-ECD7-4534-A960-32D5306E22D7

Q34203742-8556607A-080F-4180-9EF4-6226D159CC0A

Q34203742-91244EF1-8E12-47F0-BCC9-6001A2556B98

P2860

Q34203742-01179EEA-6987-43EE-97D6-04129D2532D5

Q34203742-12102CAD-A68B-4641-8EC1-BE0DED070010

Q34203742-17E91C17-714A-4294-AFD2-76320A8DDC4F

Q34203742-1AC309D6-CAD9-47D1-9E16-CBB8ED3025A5

Q34203742-1F894DBB-2892-48B4-A83D-B7D732C29EDA

Q34203742-22697635-D655-43BF-BBF6-F0EB9C494211

Q34203742-2485DBAC-5F82-44A0-8996-092E4C5438C6

Q34203742-2B0153B0-7388-48B6-9C9F-1D9437A430F2

Q34203742-317F7E8D-214D-47F1-8546-1115DE06D186

Q34203742-3C72EF30-798C-4358-86B2-BEA64834EFCB

P304

Q34203742-CB0ACF93-B4F1-4575-95F2-EC3BCB6AB503

P31

Q34203742-DCDAAA7B-DAF4-4697-A0E5-7DE451C6E6F9

P356

Q34203742-BEB42BC3-1BFA-4572-BB92-5A453076AB4A

P407

Q34203742-F132E053-432D-4E9A-AE7F-608481EB6E3E

P433

Q34203742-08EACDA8-7703-4129-B67A-4F7BE643B1D9

P478

Q34203742-F2DDAB8D-F9B1-4EFA-8931-A44FDDD9030C

P50

Q34203742-D1734F18-84F3-46BF-A6E8-9F9D62FE8C2D

P577

Q34203742-053D581F-7DED-467E-8A81-73DDD05610A3

P5875

Q34203742-0B5AA10A-1D7B-43C7-BE68-98CA320C368F

P698

Q34203742-7F510580-0EB9-4A2F-9C5C-3E70B118C18C

P921

Q34203742-324B1340-E76A-44BE-9811-1862F216E981

Q34203742-E294A895-9977-4875-A444-2E5F7E0481A5

P932

Q34203742-C5D15A97-B982-4D20-8AAD-36E886BBAED4

P356

P1433

Journal of the American Medical Association

P1476

Germline mutations in MSR1, AS ...... and esophageal adenocarcinoma.

@en

P2093

Brandie Heald

http://www.w3.org/2001/XMLSchema#string

Charissa Peterson

http://www.w3.org/2001/XMLSchema#string

Gurkan Bebek

http://www.w3.org/2001/XMLSchema#string

Jee Hoon Song

http://www.w3.org/2001/XMLSchema#string

Mohammed Orloff

http://www.w3.org/2001/XMLSchema#string

Shireen Ganapathi

http://www.w3.org/2001/XMLSchema#string

Stefan David

http://www.w3.org/2001/XMLSchema#string

Stephen J Meltzer

http://www.w3.org/2001/XMLSchema#string

Todd Romigh

http://www.w3.org/2001/XMLSchema#string

Wenjing Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Novel transcription coactivator complex containing activating signal cointegrator 1

Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene

Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

Cluster analysis and display of genome-wide expression patterns

Inflammation and cancer

PLINK: a tool set for whole-genome association and population-based linkage analyses

Principal components analysis corrects for stratification in genome-wide association studies

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

No association of germline alteration of MSR1 with prostate cancer risk

Germline ATBF1 mutations and prostate cancer risk

P304

410-419

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2011.1029

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

306

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51523493

http://www.w3.org/2001/XMLSchema#string

P698

21791690

http://www.w3.org/2001/XMLSchema#string

P921

P932

3574553

http://www.w3.org/2001/XMLSchema#string